164 related articles for article (PubMed ID: 10441163)
1. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
[TBL] [Abstract][Full Text] [Related]
2. Epitope spreading: a mechanism for progression of autoimmune disease.
Tuohy VK; Kinkel RP
Arch Immunol Ther Exp (Warsz); 2000; 48(5):347-51. PubMed ID: 11140461
[TBL] [Abstract][Full Text] [Related]
3. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
[TBL] [Abstract][Full Text] [Related]
4. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
5. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.
Zhong MC; Kerlero de Rosbo N; Ben-Nun A
J Clin Invest; 2002 Jul; 110(1):81-90. PubMed ID: 12093891
[TBL] [Abstract][Full Text] [Related]
6. Mouse models of multiple sclerosis: experimental autoimmune encephalomyelitis and Theiler's virus-induced demyelinating disease.
Fuller KG; Olson JK; Howard LM; Croxford JL; Miller SD
Methods Mol Med; 2004; 102():339-61. PubMed ID: 15286394
[TBL] [Abstract][Full Text] [Related]
7. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
8. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
[TBL] [Abstract][Full Text] [Related]
9. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
[TBL] [Abstract][Full Text] [Related]
10. Functional maturation of proteolipid protein(139-151)-specific Th1 cells in the central nervous system in experimental autoimmune encephalomyelitis.
Mohindru M; Kang B; Kim BS
J Neuroimmunol; 2004 Oct; 155(1-2):127-35. PubMed ID: 15342203
[TBL] [Abstract][Full Text] [Related]
11. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
12. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
al-Sabbagh A; Miller A; Santos LM; Weiner HL
Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
[TBL] [Abstract][Full Text] [Related]
13. Experimental autoimmune encephalomyelitis.
Rao P; Segal BM
Methods Mol Med; 2004; 102():363-75. PubMed ID: 15286395
[TBL] [Abstract][Full Text] [Related]
14. Role of MHC class II expressing CD4+ T cells in proteolipid protein(91-110)-induced EAE in HLA-DR3 transgenic mice.
Mangalam A; Rodriguez M; David C
Eur J Immunol; 2006 Dec; 36(12):3356-70. PubMed ID: 17125142
[TBL] [Abstract][Full Text] [Related]
15. Epitope spread is not critical for the relapse and progression of MOG 8-21 induced EAE in Biozzi ABH mice.
Smith PA; Morris-Downes M; Heijmans N; Pryce G; Arter E; O'Neill JK; 't Hart B; Baker D; Amor S
J Neuroimmunol; 2005 Jul; 164(1-2):76-84. PubMed ID: 15927270
[TBL] [Abstract][Full Text] [Related]
16. Induction or protection from experimental autoimmune encephalomyelitis depends on the cytokine secretion profile of TCR peptide-specific regulatory CD4 T cells.
Kumar V; Sercarz E
J Immunol; 1998 Dec; 161(12):6585-91. PubMed ID: 9862685
[TBL] [Abstract][Full Text] [Related]
17. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
[TBL] [Abstract][Full Text] [Related]
18. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
[TBL] [Abstract][Full Text] [Related]
19. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Tuohy VK; Yu M; Yin L; Kawczak JA; Johnson JM; Mathisen PM; Weinstock-Guttman B; Kinkel RP
Immunol Rev; 1998 Aug; 164():93-100. PubMed ID: 9795767
[TBL] [Abstract][Full Text] [Related]
20. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]